Experience of using a combination mucoactive drug during chemotherapy in patients with MDR/XDR tuberculosis

Experience of using a combination mucoactive drug during chemotherapy in patients with MDR/XDR tuberculosis

The objective: to evaluate the effectiveness of the medication containing a 7% NaCl solution and 0.1% sodium hyaluronate in patients with destructive pulmonary tuberculosis and multiple/extensive drug resistance (MDR/XDR) and inflammatory changes in the tracheobronchial tree. Subjects and methods. A...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. P. Myshkova, S. V. Sklyuev, E. M. Zhukova, D. V. Krasnov, T. I. Petrenko
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2020-08-01
Series:	Туберкулез и болезни лёгких
Subjects:	mucoactive therapy destructive pulmonary tuberculosis with mdr/xdr inflammation of the tracheobronchial tree
Online Access:	https://www.tibl-journal.com/jour/article/view/1441
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The effect of the current chemotherapy of MDR/XDR tuberculosis on QT interval changes in ECG
by: E. M. Zhukova, et al.
Published: (2019-12-01)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
by: Luigi R. Codecasa, et al.
Published: (2017-01-01)

Impacts of MDR/XDR-TB on the global tuberculosis epidemic: Challenges and opportunities
by: Kai Ling Chin, et al.
Published: (2024-01-01)

Identification of Acinetobacter baumannii and Determination of MDR and XDR Strains
by: Noor Hussein Ahmad, et al.
Published: (2020-07-01)

Genotypic and Phenotypic Methods in the Detection of MDR-TB and Evolution to XDR-TB
by: Natalia Zaporojan, et al.
Published: (2025-07-01)

An Overview of Mucoactive Agents
by: Li-Sang Hsu, et al.
Published: (2020-10-01)

Safety of chemotherapy of MDR/XDR-TB patients in high HIV prevalence settings
by: A. V. Kukurika, et al.
Published: (2022-12-01)

The growing concern of MDR/XDR bacteria in patients undergoing dialysis: a cross-sectional study
by: Noor S. Kadhem, et al.
Published: (2025-06-01)

Perspectives of targeted chemotherapy with delamanid in the treatment regimens of those with multiple/extensive drug resistant tuberculosis. A success, chance or uncertainty?
by: Aleksey G. Naumov, et al.
Published: (2018-11-01)

Delamanid in the Treatment of MDR/pre-XDR TB in Arkhangelsk Region in 2019–2021
by: E. S. Khimova, et al.
Published: (2023-07-01)

Pharmacological approaches to the rational choice of combined mucoactive drugs
by: S. V. Okovity, et al.
Published: (2021-06-01)

Mucoactive cough therapy: what is behind the horizon?
by: A. A. Zaitsev
Published: (2021-06-01)

The Role of Risk Factors in the Development of Tuberculosis in Children Exposed to Rifampicin Resistant Tuberculosis
by: N. A. Nikiforenko, et al.
Published: (2021-08-01)

Active phytoconstituents to tackle the resistance mechanism of MDR and XDR bacteria: A critical review
by: Subhasmita Mallik, et al.
Published: (2025-08-01)

A Survival Analysis of Successful and Poor Treatment Outcome Among Patients with Drug-Resistant Tuberculosis and the Associated Factors: A Retrospective Cohort Study
by: Putri Bungsu Machmud, et al.
Published: (2021-07-01)

Comparative analysis of eﬃcacy and safety of various anti-tuberculosis therapy regimens in patients with MDR/XDR tuberculosis
by: E. P. Myshkova, et al.
Published: (2022-06-01)

Features of endobronchial pathology among patients with chemoresistant tuberculosis of lungs depending on a case of the previous disease
by: O. M. Raznatovska, et al.
Published: (2017-08-01)

Frequency and Structure of Drug Resistance of M. tuberculosis in Pulmonary and Extrapulmonary Tuberculosis
by: P. K. Yablonskiy, et al.
Published: (2024-03-01)

Eﬃcacy and safety of short course chemotherapy regimens in older children and adolescents with multiple and extensive drug resistant respiratory tuberculosis
by: L. V. Panova, et al.
Published: (2021-11-01)

Short-Course Chemotherapy Regimens for Treatment of Multiple and Pre-Extensive Drug Resistant Tuberculosis in Combination with Surgery in Older Children and Adolescents
by: E. S. Ovsyankina, et al.
Published: (2024-12-01)

Communicable Episode 20: Tuberculosis today
by: Kathryn Hostettler, et al.
Published: (2025-06-01)

XDR TB in South Africa - What lies ahead?
by: V. Thaver, et al.
Published: (2007-12-01)

QT-Interval Prolongation in the Treatment of Drug-Resistant Tuberculosis
by: A. V. Kukurika
Published: (2024-03-01)

The Dissemination of Multidrug Resistance (MDR) and Extensively Drug Resistant (XDR) among Uropathogenic E. coli (UPEC) Isolates from Urinary Tract Infection Patients in Babylon Province, Iraq
by: Al-Hasnawy et al.
Published: (2019-12-01)

THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2017-11-01)

TB financing in East Europe promotes unnecessary hospital admissions: the case of Armenia
by: Laura Gillini, et al.
Published: (2013-03-01)

Efficacy of EA575 as an Antitussive and Mucoactive Agent in Preclinical In Vivo Models
by: Matthias Hufnagel, et al.
Published: (2025-07-01)

TUBERCULOSIS WITH CONCURRENT HIV INFECTION IN RUSSIA: STATISTICS AND CORRELATIONS
by: E. B. Tsybikova, et al.
Published: (2019-01-01)

Prevalence and contributing factors of drug-resistant tuberculosis (DR-TB) in iran: a systematic review
by: Salman Daneshi, et al.
Published: (2025-08-01)

Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort studyResearch in context
by: Yousra Kherabi, et al.
Published: (2025-09-01)

Virulence traits, agr typing, multidrug resistance patterns, and biofilm ability of MDR Staphylococcus aureus recovered from clinical and subclinical mastitis in dairy cows
by: Nada H. Eidaroos, et al.
Published: (2025-03-01)

Xpert MTB/XDR Assay for Detection of Resistance to Isoniazid, Fluoroquinolone, Aminoglycoside, and Ethionamide Among Patients with Pulmonary Tuberculosis in Bangladesh
by: S. M. Mazidur Rahman, et al.
Published: (2025-03-01)

MULTI DRUG RESISTANT TUBERCULOSOS IN THE COUNTRIES OF THE OUTER WORLD AND IN THE RUSSIANFEDERATION
by: I. А. Vаsilyevа, et al.
Published: (2017-12-01)

Resistance and heteroresistance to colistin among multidrug-resistant and extensively drug-resistant Gram-negative organisms isolated from patients admitted to Zagazig University Hospitals
by: Salah Al-Sayed Ibrahim Ali, et al.
Published: (2025-03-01)

INDIVIDUAL TREATMENT OF PULMONARY MDR/XDR TUBERCULOSIS IN ADOLESCENTS
by: L. V. Pаnovа, et al.
Published: (2018-03-01)

Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance
by: N. Yu. Nikolenko, et al.
Published: (2023-07-01)

The multivariate analysis of results of bedaquiline use in the therapy of MDR/XDR pulmonary tuberculosis
by: N. V. Stavitskaya, et al.
Published: (2020-08-01)

Preliminary remarks on assembly whole genome sequencing of MDR M. tuberculosis isolated in Vietnam
by: Ngo Viet Quynh Tram, et al.
Published: (2011-12-01)

Testing Susceptibility of <i>M. tuberculosis</i> to Second Line Anti-Tuberculosis Drugs Using the XDR Test in Clinical Trials and International Professional Testing Cycles
by: L. V. Domotenko, et al.
Published: (2021-09-01)

Bacteremia in a human caused by an XDR strain of Pseudomonas fulva
by: Fakhur Uddin, et al.
Published: (2018-07-01)